World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
72
Citations
32492
World Ranking
1706
National Ranking
732

James D. Chappell publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where James D. Chappell sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 284 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

James D. Chappell D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where James D. Chappell sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 72 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

James D. Chappell is affiliated with Vanderbilt University Medical Center in the United States. Their research primarily spans the fields of Medicine, with a strong focus on Infectious Diseases, Epidemiology, and related subfields such as Health, Pulmonary and Respiratory Medicine, and Modeling and Simulation.

The scientist's work often revolves around respiratory and viral infections, with a significant emphasis on SARS-CoV-2 and COVID-19 research. Major research topics include:

  • SARS-CoV-2 and COVID-19 Research
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • COVID-19 Clinical Research Studies
  • Influenza Virus Research Studies
  • Vaccine Coverage and Hesitancy
  • COVID-19 epidemiological studies

Chappell has published extensively in various scientific venues, frequently contributing to:

  • Open Forum Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • MMWR Morbidity and Mortality Weekly Report
  • The Journal of Infectious Diseases

They have collaborated often with a select group of coauthors, including:

  • Natasha Halasa
  • Carlos G. Grijalva
  • Adam S. Lauring
  • Yuwei Zhu
  • Wesley H. Self

Among recent significant publications are:

  • "An mRNA Vaccine against SARS-CoV-2 - Preliminary Report" (2020) published in New England Journal of Medicine
  • "Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults" (2020) published in New England Journal of Medicine
  • "SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness" (2020) published in Nature
  • "An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice" (2020) published in Science Translational Medicine
  • "Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination" (2020) published in New England Journal of Medicine

Best Publications

  • Community-acquired pneumonia requiring hospitalization among U.S. adults

    Seema Jain;Derek J. Williams;Sandra R. Arnold;Krow Ampofo

  • An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

    Lisa A. Jackson;Evan J. Anderson;Nadine G. Rouphael;Paul C. Roberts

  • Community-acquired pneumonia requiring hospitalization among U.S. children.

    Unknown

  • SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.

    Kizzmekia S. Corbett;Darin K. Edwards;Sarah R. Leist;Olubukola M. Abiona

  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

    Evan J. Anderson;Nadine G. Rouphael;Alicia T. Widge;Lisa A. Jackson

  • Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

    Jesper Pallesen;Nianshuang Wang;Kizzmekia S. Corbett;Daniel Wrapp

  • An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.

    Timothy P. Sheahan;Amy C. Sims;Shuntai Zhou;Rachel L. Graham

  • Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

    Alicia T. Widge;Nadine G. Rouphael;Lisa A. Jackson;Evan J. Anderson

  • Norovirus and Medically Attended Gastroenteritis in U.S. Children

    Daniel C. Payne;Jan Vinjé;Peter G. Szilagyi;Kathryn M. Edwards

  • Junction Adhesion Molecule Is a Receptor for Reovirus

    Erik S Barton;J.Craig Forrest;Jodi L Connolly;James D Chappell

  • Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

    Unknown

  • Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

    Mark W Tenforde;Wesley H Self;Katherine Adams;Manjusha Gaglani

  • Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1) in Argentina

    Romina Libster;Jimena Bugna;Silvina Coviello;Diego R. Hijano

  • Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.

    Andrea J. Pruijssers;Andrea J. Pruijssers;Amelia S. George;Amelia S. George;Alexandra Schäfer;Sarah R. Leist

  • Middle East Respiratory Syndrome

    Yaseen M. Arabi;Hanan H. Balkhy;Frederick G. Hayden;Abderrezak Bouchama

  • Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.

    Wesley H. Self;Mark W. Tenforde;Jillian P. Rhoads;Manjusha Gaglani;Manjusha Gaglani

  • A Plasmid-Based Reverse Genetics System for Animal Double-Stranded RNA Viruses

    Takeshi Kobayashi;Annukka A.R. Antar;Karl W. Boehme;Pranav Danthi

  • Small-Molecule Antiviral β-d- N 4 -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance.

    Maria L. Agostini;Andrea J. Pruijssers;James D. Chappell;Jennifer Gribble

  • Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening.

    Erik S. Barton;Jodi L. Connolly;J. Craig Forrest;James D. Chappell

  • Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia

    Wesley H. Self;Derek J. Williams;Yuwei Zhu;Krow Ampofo

  • Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes

    Ana Clara Monsalvo;Juan P Batalle;M Florencia Lopez;Jens C Krause

  • Crystal structure of reovirus attachment protein σ1 reveals evolutionary relationship to adenovirus fiber

    James D. Chappell;Andrea E. Prota;Terence S. Dermody;Thilo Stehle

Frequent Co-Authors

Terence S. Dermody
Terence S. Dermody University of Pittsburgh
Natasha Halasa
Natasha Halasa Vanderbilt University Medical Center
Mark R. Denison
Mark R. Denison Vanderbilt University Medical Center
Kathryn M. Edwards
Kathryn M. Edwards Vanderbilt University Medical Center
Peter G. Szilagyi
Peter G. Szilagyi University of California, Los Angeles
Geoffrey A. Weinberg
Geoffrey A. Weinberg University of Rochester
Umesh D. Parashar
Umesh D. Parashar Centers for Disease Control and Prevention
Michael D. Bowen
Michael D. Bowen Centers for Disease Control and Prevention
Carlos G. Grijalva
Carlos G. Grijalva Vanderbilt University Medical Center
Janet A. Englund
Janet A. Englund Seattle Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology in the USA opens numerous career opportunities beyond traditional lab work. Many graduates explore healthcare roles that combine biological insights with patient care. For instance, becoming a functional medicine nurse allows professionals to apply a holistic approach to patient health, integrating microbiology knowledge with medical practice.

For those interested in the administrative and technical side of healthcare, certification as a professional coder certification boosts job prospects. This role plays a vital part in accurately documenting diagnoses and treatments, which is crucial for healthcare operations and billing.

The field of health information management also aligns well with a microbiology background. Pursuing a best online health information management degree cahiim accredited program provides students with essential skills to manage healthcare data efficiently and adhere to compliance standards.

Graduates with advanced degrees often consider careers as health information managers, who enjoy competitive salaries and leadership roles within healthcare systems. Learning about the master in health information management salary can help candidates assess the long-term benefits of this career pathway.

Best Scientists Citing James D. Chappell

Trending Scientists

Recently Published Articles